v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | ACTRN12622000742774 |
Full text link
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
|
First author
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
|
Contact
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
raden-a@fk.unair.ac.id |
Registration date
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
2022-05-24 |
Recruitment status
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Not recruiting |
Study design
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
RCT |
Allocation
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Randomized |
Design
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Parallel |
Masking
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Blind label |
Center
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
unclear |
Study aim
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Long covid |
Inclusion criteria
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Participants with long COVID-19 criteria (3-12 months after the diagnosis of SARS-Cov-2 infection, continue to have signs and symptoms not explainable by other causes) in accordance with the guideline of the National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP) |
Exclusion criteria
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Patients post-acute COVID-19 without symptoms Have a musculoskeletal condition that impairs their ability to undertake exercise training. |
Number of arms
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
2 |
Funding
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Universitas Airlangga |
Inclusion age min
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
18 |
Inclusion age max
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
70 |
Countries
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Indonesia |
Type of patients
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Patients recovered from covid |
Severity scale
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
N/A |
Total sample size
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
100 |
primary outcome
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Vascular endothelial function (composite primary outcome): Assessed via flow-mediated dilation which is a non-invasive high-resolution ultrasound (Terason; t3200; Burlington; MA 01803; USA) imaging technique of the brachial artery which will be performed on the arm. Images will be optimised and recordings taken during a 1 minute resting baseline which will be followed by the inflation of an occlussion cuff for 5 min to 220 mmHg around the forearm. Scanning will be continued following deflation of the cuff for 3 min. Continuous (30 Hz) brachial lumen cross-sectional area and Doppler velocity will be used to calculate brachial blood flow and shear stress; along with changes in arterial diameter. FMD will be calculated in absolute (mm) and relative (%) terms as the increase from the 1 min resting baseline diameter.[Vascular endothelial function will be assessed at baseline and 3 days after the last exercise session (to prevent the influence of the last exercise)];Respiratory function will be assessed as a composite primary outcome. This outcome will be measured by spirometry (BTL 08 Spiro; United Kingdom). There are 3 measurements that will be assessed: relaxed; forced (with and without bronchodilator); and maximal voluntary volume (MVV). Prior to performing spirometry; the patient's identification is checked. The participants grip the pneumotachometer in sitting position and will perform the spirometer test in following sequence: 1. Relaxed spirometry: The participants enclose the mouthpiece of the spirometer in their lips and breathe calmly; and then they will be asked to perform a maximal deep expiration without major effort until all the air is emptied from the lungs; and then slowly breathe until the maximum aspiration (so-called expiratory vital capacity procedure) and ask them again to perform everything conversely (so-called inspiratory vital capacity procedure).2. Forced Spirometry: the participants will be asked to take a deep breath in; as large as possible aside from the spirometric module. Immediately after that; enclose the mouthpiece of the spirometer in his lips and blows out as hard and as fast as possible and keep going until there is no air left; continue with a deep breath in.3. MVV: The participants enclose the mouthpiece of the spirometer in their lips and breathe calmly and then continue with deep and fast breathing for 20 seconds.4. Bronchodilator inhalation (400 µg of salbutamol)5. Repeat forced spirometry test; 4-5 minutes after bronchodilator inhalationAll the tests will be performed 3x by following the instructor's guidance and will be encouraged verbally to achieve optimal results.[Respiratory function will be assessed at baseline and 3 days after the last exercise session (to prevent the influence of the last exercise).];Cardiorespiratory fitness will be measured by 5 meters walking test. The participants will be asked to walk at a comfortable pace for 5 feet before the start; and 5 feet after the middle 5-meter section. The participants will perform 3 repetitions and calculate the average time. [Cardiorespiratory fitness will be assessed at baseline and 3 days after exercise training (to prevent the influence of the last exercise).] |
Notes
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
|
Phase
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Not reported |
Arms
Last imported at : June 2, 2022, 8 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
[{"arm_notes": "", "treatment_id": 41, "treatment_name": "Aerobic exercise", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |